Edition:
United States

People: OPKO Health Inc (OPK.O)

OPK.O on Nasdaq

1.83USD
23 Aug 2019
Change (% chg)

$-0.12 (-6.15%)
Prev Close
$1.95
Open
$1.94
Day's High
$1.96
Day's Low
$1.83
Volume
3,195,399
Avg. Vol
4,366,503
52-wk High
$6.16
52-wk Low
$1.73

Pfenniger, Richard 

Mr. Richard C. Pfenniger, Jr., serves as Independent Director of the Company. Mr. Pfenniger served as Interim CEO of Vein Clinics of America, Inc., a privately held company that specializes in the treatment of vein disease, from May 2014 to February 2015 and as Interim CEO of IntegraMed America, Inc., a privately held company that manages outpatient fertility medical centers, from January 2013 to June 2013. He served as Chief Executive Officer and President for Continucare Corporation, a provider of primary care physician and practice management services, from 2003 until 2011, and served as Chairman of the Board of Directors of Continucare Corporation from 2002 until 2011. Previously, Mr. Pfenniger served as the Chief Executive Officer and Vice Chairman of Whitman Education Group, Inc. from 1997 through June 2003. Prior to joining Whitman, he served as the Chief Operating Officer of IVAX from 1994 to 1997, and, from 1989 to 1994, he served as the Senior Vice President-Legal Affairs and General Counsel of IVAX Corporation. Prior thereto he was engaged in the private practice of law. Mr. Pfenniger currently serves as a director of GP Strategies Corporation (NYSE:GPX), a corporate education and training company, TransEnterix, Inc. (NYSE American:TRXC), a medical device company, BioCardia, Inc. (OTC US:BCDA), clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases, and IntegraMed America, Inc. (NASDAQ:INMD), a specialty healthcare services company offering products and services to patients and providers in the fertility and vein care segments of the health industry. He also serves as the Vice Chairman of the Board of Trustees and as a member of the Executive Committee of the Phillip and Patricia Frost Museum of Science. Mr. Pfenniger previously served as a director of Vein Clinics of America and Wright Investors’ Services Holdings, Inc. (OTC US:WISH), an investment management and financial advisory firm.

Basic Compensation

Total Annual Compensation, USD 35,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 60,000
Fiscal Year Total, USD 95,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Phillip Frost

2,036,000

Geoff Monk

--

Jane Hsiao

1,976,000

Adam Logal

1,250,000

Jon Cohen

--

Steven Rubin

1,460,000
As Of  30 Dec 2018